New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
04:55 EDTATHN, ATHN, JNJ, JNJ, CERN, CERN, UNH, UNH, SNY, SNY, PFE, PFE, MDT, MDT, CAH, CAH, BCR, BCR, AGTC, AGTCPiper Jaffray to hold a summit
3rd Annual Heartland Summit to be held in Minneapolis on August 6-7.
News For ATHN;BCR;CAH;MDT;PFE;SNY;UNH;CERN;JNJ;AGTC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
June 23, 2015
14:17 EDTPFEGlycoMimetics to receive $20M payment from Pfizer
Subscribe for More Information
14:01 EDTPFEPfizer announces enrollment of first patient in RESET study
Subscribe for More Information
11:20 EDTMDTMedtronic competitive with Edwards after approval, says Wells Fargo
Subscribe for More Information
09:53 EDTPFEPfizer management to meet with FBN Securities
Meeting to be held in New York on June 25 hosted by FBN Securities.
09:22 EDTMDTMedtronic announces FDA approval for new TAVR system
Subscribe for More Information
07:25 EDTUNH, CAH, BCR, PFE, MDTPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
June 22, 2015
08:52 EDTPFEPortola, Bristol-Myers, and Pfizer announce results from Phase 3 ANNEXA study
Subscribe for More Information
07:05 EDTCERNCerner management to meet with FBR Capital
Subscribe for More Information
07:01 EDTPFEPfizer to acquire Nimenrix, Mencevax from GlaxoSmithKline for $130M
Pfizer (PFE) announced that it has entered into an agreement with GlaxoSmithKline (GSK) to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for a total consideration of approximately $130M. This transaction will add two high-quality and complementary vaccines to Pfizer’s portfolio, allowing the company to reach a broader global population. Nimenrix is a single dose meningococcal ACWY-TT conjugated vaccine designed to protect against Neisseria meningitidis, an uncommon but highly contagious disease that can lead to disability and death. Mencevax is a single-dose meningococcal ACWY unconjugated polysaccharide vaccine used to control outbreaks of meningococcal infection and for travelers to countries where the disease is endemic or highly epidemic. Pfizer does not expect this transaction to have any significant impact on its 2015 financial performance. The transaction is subject to customary closing conditions as well as regulatory approvals in several markets, and is expected to occur in the second half of 2015. Pfizer’s legal advisors for the transaction were Ropes & Gray and Clifford Chance.
06:51 EDTUNHHealth insurer tie-ups could cut competition, WSJ reports
Subscribe for More Information
06:37 EDTUNHHealth insurers may change policies based on King v. Burwell ruling, NYT says
Subscribe for More Information
June 21, 2015
16:03 EDTUNHAetna makes offer to acquire Humana, WSJ says
Subscribe for More Information
12:42 EDTMDTMedtronic reports five-year follow-up results for Endurant AAA stent graft
Subscribe for More Information
June 19, 2015
17:02 EDTMDTMedtronic acquires Aptus Endosystems for $110M
Medtronic announced it has acquired the assets of Aptus Endosystems, a Sunnyvale, Calif. based, privately held medical device company focused on developing advanced technology for endovascular aneurysm repair and thoracic endovascular aneurysm repair. Medtronic completed its acquisition of the assets of Aptus Endosystems in a transaction valued at approximately $110M. Additional terms of the acquisition were not disclosed.
16:24 EDTUNHStocks end week higher after Fed reassures on gradual pace of rate increases
Subscribe for More Information
10:09 EDTUNHFly Watch: Supreme Court may release key ACA decision soon
Subscribe for More Information
09:23 EDTMDTMedtronic acquires CardioInsight Technologies
Subscribe for More Information
09:21 EDTMDTMedtronic approves repurchase of addition 80M shares
Subscribe for More Information
09:20 EDTMDTMedtronic raises quarterly dividend by 25% to 38c per share
The board of Medtronic approved a 25% increase in its cash dividend for FY16, raising the quarterly amount to 38c per ordinary share for an annual amount of $1.52 per ordinary share. The dividend is payable on July 17, to shareholders of record at the close of business on June 29.
07:37 EDTUNHSupreme Court decision on ACA suit due soon, says UBS
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use